期刊文献+

Molecular characteristics of rifampin and isoniazid resistant Mycobacterium tuberculosis strains from Beijing,China 被引量:39

Molecular characteristics of rifampin and isoniazid resistant Mycobacterium tuberculosis strains from Beijing,China
原文传递
导出
摘要 Background China is one of the high burden countries of Mycobacterium tuberculosis (TB) infection globally, with high incidence and mortality. We studied the molecular characteristics of rifampin (RIF) and isoniazid (INH) resistant Mycobacterium tuberculosis strains from Beijing, China, in order to find out the genetic marker for rapid detection of specific drug resistance.Methods Forty pansusceptible and 81 resistant strains of Mycobacterium tuberculosis isolated from Beijing, China during 2002-2005 were analyzed. The modified rifampin oligonucleotide (RIFO) assay based on reverse line blot hybridization was used to detect mutations in the 81 bp hot-spot region of rpoB gene, which is associated with RIF resistance. The INH resistance associated genes, regulatory region mab-inhA (-15C/T) and structural gene katG S315T were detected by reverse line blot hybridization and PCR-restriction fragment length polymorphism (RFLP) method respectively. All the strains were typed by spoligotying and the Beijing genotype was further subdivided by NTF locus analysis. The distribution of drug resistance associated mutations in the above genes was compared in these groups. Results Sixty-five (91.5%) of 71 RIF resistant and 52 (92.9%) of 56 multidrug-resistant (MDR, i.e. resistant to at least RIF and INH) strains were found to harbor mutations in the rpoB hot-spot region. No mutation was detected in RIF sensitive strains. The specificity and sensitivity of the modified RIFO assay were 100% and 91.5%, respectively, katG315 AGC〉ACC and inhA-15C〉T mutations were found in 40 (60.6%) and 10 (15.2%) of 66 INH resistant strains, respectively; 7.6% of INH-resistant strains had mutations in both of these genes. Therefore, a combined use of both katG315 and inhA-15 identified 68.2% of INH-resistant strains. The Beijing genotype accounted for 91.7% of total strains and was further subdivided into "modern" (76.6%) and "ancestral" (23.4%) group. There is no significant difference between "ancestral" and "modern" group in prevalance of drug resistance-associated gene mutations. Conclusions The hot-spot region of rpoB gene can be used as genetic marker for detection of RIF resistant strains; a combined use of both katG315 and inhA-15 can improve the detection rate of I NH resistant strains; the Beijing genotype is prevalent in Beijing, China; the modified RIFO assay can be a practical tool for rapid detection of RIF resistant and MDR isolates in the routine diagnostic work. Background China is one of the high burden countries of Mycobacterium tuberculosis (TB) infection globally, with high incidence and mortality. We studied the molecular characteristics of rifampin (RIF) and isoniazid (INH) resistant Mycobacterium tuberculosis strains from Beijing, China, in order to find out the genetic marker for rapid detection of specific drug resistance.Methods Forty pansusceptible and 81 resistant strains of Mycobacterium tuberculosis isolated from Beijing, China during 2002-2005 were analyzed. The modified rifampin oligonucleotide (RIFO) assay based on reverse line blot hybridization was used to detect mutations in the 81 bp hot-spot region of rpoB gene, which is associated with RIF resistance. The INH resistance associated genes, regulatory region mab-inhA (-15C/T) and structural gene katG S315T were detected by reverse line blot hybridization and PCR-restriction fragment length polymorphism (RFLP) method respectively. All the strains were typed by spoligotying and the Beijing genotype was further subdivided by NTF locus analysis. The distribution of drug resistance associated mutations in the above genes was compared in these groups. Results Sixty-five (91.5%) of 71 RIF resistant and 52 (92.9%) of 56 multidrug-resistant (MDR, i.e. resistant to at least RIF and INH) strains were found to harbor mutations in the rpoB hot-spot region. No mutation was detected in RIF sensitive strains. The specificity and sensitivity of the modified RIFO assay were 100% and 91.5%, respectively, katG315 AGC〉ACC and inhA-15C〉T mutations were found in 40 (60.6%) and 10 (15.2%) of 66 INH resistant strains, respectively; 7.6% of INH-resistant strains had mutations in both of these genes. Therefore, a combined use of both katG315 and inhA-15 identified 68.2% of INH-resistant strains. The Beijing genotype accounted for 91.7% of total strains and was further subdivided into "modern" (76.6%) and "ancestral" (23.4%) group. There is no significant difference between "ancestral" and "modern" group in prevalance of drug resistance-associated gene mutations. Conclusions The hot-spot region of rpoB gene can be used as genetic marker for detection of RIF resistant strains; a combined use of both katG315 and inhA-15 can improve the detection rate of I NH resistant strains; the Beijing genotype is prevalent in Beijing, China; the modified RIFO assay can be a practical tool for rapid detection of RIF resistant and MDR isolates in the routine diagnostic work.
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2007年第9期814-819,共6页 中华医学杂志(英文版)
基金 This study was supported by a grant from the National Natural Science Foundation of China(No.30471841).
关键词 Mycobacterium tuberculosis drug resistance RIFAMPIN ISONIAZID Mycobacterium tuberculosis drug resistance rifampin isoniazid
  • 相关文献

参考文献10

  • 1National technic steering group of the epidemiological sampling survey for tuberculosis.Report on fourth national epidemiological sampling survey of tuberculosis[].Chin J Tuberc Resp Dis.2002
  • 2C.Dye,,S.Scheele,,P.Dolin,V.Pathania.Conesensus statement.Global burden of tuberculosis;estimated incidence,prevalence,and mortality by country[].WHO Global Surveillance and Monitoring ProjectJAMA.1999
  • 3.Global tuberculosis control: surveillance, planning, financing[].(WHO/HTM/TB/).2006
  • 4Ramaswamy S,Musser J M.Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis:1998 update[].Tuberculosis Lung Dis.1998
  • 5van,Embden,JDA,Cave,MD,Crawford,JT,Dale,JW,Eisenach,KD,Gicquel,B,Hermans,P,Martin,C,McAdam,R,Shinnik,TM,Small,PM.Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology[].Journal of Clinical Microbiology.1993
  • 6Mokrousov,I,Bhanu,NV,Suffys,PN,Kadival,GV,Yap,SF,Cho,SN,Jordaan,AM,Narvskaya,O,Singh,UB,Gomes,HM,Lee,H,Kulkarni,SP,Lim,KC,Khan,BK,van,Soolingen,D,Victor,TC,Schouls,LM.Multicenter evaluation of reverse line blot assay for detection of drug resistance in Mycobacterium tuberculosis clinical isolates[].Journal of Microbiological Methods.2004
  • 7Kamerbeek,J,Schouls,L,Kolk,A,van,Agterveld,M,van,Soolingen,D,Kuijper,S,Bunschoten,A,Molhuizen,H,Shaw,R,Goyal,M,van,Embden,J.Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology[].Journal of Clinical Microbiology.1997
  • 8Werngren J,Hoffner S E.Drug-susceptible Mycobacterium tuberculosis Beijing genotype does not develop mutation-conferred resistance to rifampin at an elevated rate[].Journal of Clinical Microbiology.2003
  • 9Rad,ME,Bifani,P,Martin,C,Kremer,K,Samper,S,Rauzier,J.Mutations in putative mutator genes of Mycobacterium tuberculosis strains of the W-Beijing family[].Emerging Infectious Diseases.2003
  • 10Dobner P,Rusch-Gerdes S,Bretzel G,et al.Usefulness of Mycobacterium tuberculosis genomic mutations in the genes katG and inhA for the prediction of isniazid resistance[].International Journal of Tuberculosis and Lung Disease.1997

同被引文献218

引证文献39

二级引证文献238

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部